# Shanghai Changde Medical Technology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/shanghai-changde-medical-technology

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Website: www.easyflowmedtech.com
- Latest round: Series A (Apr 23, 2025)
- Investors on record: 4

## About

Established in 2021 and based in Shanghai, China, Shanghai Changde Medical Technology operates as a peripheral vascular intervention device products developer that provides peripheral vascular intervention device products. The company cooperates with Control Medical and introduces its Control ™ mechanical thrombus clearance system. In April 2025, it closed a series A+ funding led by new investor Shanghai Healthcare Capital, with participation from other new investor Xingzheng Capital.

The company focuses on peripheral arteriovenous disease and provides peripheral vascular intervention device products. Its R&D projects include drug balloon, catheter, stent and thrombus removal equipment. Its self-developed products such as the peripheral vascular constraint balloon dilatation catheter EF-Rhine.

The company generates revenue by providing peripheral vascular intervention device products. 

The company will use the funds for pre-market clinical trials and registration applications for innovative products, international registration of core products, and market expansion.

## Funding rounds

- Series A, Apr 23, 2025 — Legend Capital, Shanghai Healthcare Capital, Industrial Securities Capital, Huajie Gaojing Management Consulting (Beijing)
- Angel, Oct 24, 2022 — Legend Capital

## Investors

- Legend Capital — Angel, Series A
- Shanghai Healthcare Capital (https://capitalatlas.ai/funds/shanghai-healthcare-capital) — Series A
- Industrial Securities Capital — Series A
- Huajie Gaojing Management Consulting (Beijing) — Series A